Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase EARLY_PHASE1 2Phase 3 1

Status

Unknown 3

Sponsor Class

OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3CNS 1Breast 1

Conditions

Hypertension, Portal 3Carcinoma, Hepatocellular 3Liver Cirrhosis 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 16Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Gemcitabine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Drug Therapy 5Control Groups 5Cisplatin 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Sodium Chloride 4Ropivacaine 4Ribavirin 4Hepatectomy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Propranolol × Gastrointestinal × Clear all
NCT01451658 2019-09-04

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01970748 2019-08-30

P-HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡